The Berlin-Frankfurt-Münster Protocol for the Upfront Treatment of Aggressive Lymphomas: The Bologna Experience

American Journal of Hematology - United States
doi 10.1002/ajh.25152
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Treatment of High Risk Aggressive B Cell Lymphomas With Da Epoch R- The Austrian Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Gemtuzumab Ozogamicin in Children With Relapsed or Refractory Acute Myeloid Leukemia: A Report of Berlin-Frankfurt-Münster Study Group

Haematologica
Hematology
2018English

The Aggressive Peripheral T-Cell Lymphomas: 2017

American Journal of Hematology
Hematology
2017English

Second Malignancies After Treatment of Childhood Non-Hodgkin Lymphoma: A Report of the Berlin-Frankfurt-Muenster Study Group

Haematologica
Hematology
2020English

Correction To: Aggressive Lymphomas

Technik im Fokus
2019English

Lessons From the ECB Experience: Frankfurt Still Matters!

Economic Notes
EconomicsEconometrics
2008English

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

Cancers
Cancer ResearchOncology
2020English

Outcomes in the Treatment of Patients With T-Cell Non-Hodgkin's Lymphomas. The Experience of Single Institution

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Upfront Nephrectomy for the Treatment of Wilms Tumor: Outcomes and Predictors of Complications

Journal of Child Science
Child HealthSurgeryPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy